International Journal of Nephrology / 2017 / Article / Tab 5

Clinical Study

Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study

Table 5

Parameters of the patients at 12 months.

Denosumab groupControl group value

Corrected Ca (mg/dl)9.1 ± 0.69.1 ± 0.4NS
Phosphate (mg/dl)5.1 ± 1.44.6 ± 0.9NS
W-PTH (pg/ml)128 (72 to 191)140 (76 to 215)NS
ALP (U/l)185 ± 59249 ± 65

The reference range for ALP is from 115 to 359 U/l. Median and interquartile range are shown for whole PTH.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.